Developing Workflow for Simultaneous Analyses of Phosphopeptides and Glycopeptides.


Journal

ACS chemical biology
ISSN: 1554-8937
Titre abrégé: ACS Chem Biol
Pays: United States
ID NLM: 101282906

Informations de publication

Date de publication:
18 01 2019
Historique:
pubmed: 12 12 2018
medline: 7 1 2020
entrez: 12 12 2018
Statut: ppublish

Résumé

Enrichment of modified peptides from global peptides is inevitable in mass spectrometric analysis protein modifications because of their importance in the study of cellular functions and low abundance in the global proteomic analysis. Recent advances in enrichment methods for modified peptides such as phosphopeptides and intact glycopeptides (IGPs) show that the methods for proteomic analyses of both protein modifications are robust. We have recently observed and reported a large number of IGPs from phosphoproteomic analysis using IMAC-based phosphopeptides enrichment procedure. To determine whether phosphorylated peptides could be specifically isolated from coenriched IGPs in IMAC experiments with different pH, IMAC procedures were performed at different pH conditions, and we found that the enrichment of phosphopeptides at pH 2.0 was the optimal condition for having the highest number of phosphopeptide identifications; however, coenrichment of phosphopeptides and glycopeptides was inevitable in the entire pH range. The hydrophilic enrichments of IGPs performed before or after IMAC enrichment were evaluated subsequently to determine the optimal workflow for simultaneous analyses of phosphopeptides and glycopeptides, and IMAC enrichment followed by hydrophilic enrichment was chosen as the optimized workflow. Applying the workflow to the TMT-labeled peptides from luminal and basal-like type of breast cancer patient-derived xenograft (PDX) models allowed quantitative analyses of phospho- and glycoproteomics with 17582 phosphopeptides and 3468 glycopeptides identified, and 1237 phosphopeptides and 236 glycopeptides showed significant expression differences between luminal and basal-like, respectively. This method allows simultaneous analyses of phosphoprotein and glycoprotein modifications, extending our understanding of roles of glycosylation and phosphorylation in biology and diseases.

Identifiants

pubmed: 30525447
doi: 10.1021/acschembio.8b00902
pmc: PMC6624649
mid: NIHMS1036178
doi:

Substances chimiques

Glycopeptides 0
Phosphopeptides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-66

Subventions

Organisme : NCI NIH HHS
ID : U24 CA210985
Pays : United States

Références

Nat Biotechnol. 2003 Jun;21(6):660-6
pubmed: 12754519
Nat Protoc. 2010 Dec;5(12):1974-82
pubmed: 21127490
Anal Chem. 2008 Jan 1;80(1):62-76
pubmed: 18027909
Annu Rev Pharmacol Toxicol. 2009;49:199-221
pubmed: 18834307
Anal Biochem. 1986 Apr;154(1):250-4
pubmed: 3085541
Anal Chem. 1999 Jul 15;71(14):2883-92
pubmed: 10424175
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Nat Biotechnol. 2016 Jan;34(1):84-8
pubmed: 26571101
Proteomics. 2005 Nov;5(17):4389-97
pubmed: 16222723
Cancer Res. 2017 Apr 1;77(7):1564-1574
pubmed: 28202516
Proteomics. 2009 Oct;9(20):4632-41
pubmed: 19743430
Mol Cell Proteomics. 2007 Oct;6(10):1778-87
pubmed: 17623646
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Mol Cell Proteomics. 2015 Oct;14(10):2753-63
pubmed: 26256267
Protein Sci. 1993 Feb;2(2):183-96
pubmed: 7680267
J Biol Chem. 2002 Oct 18;277(42):39379-87
pubmed: 12151408
Anal Chem. 2009 Jan 1;81(1):503-8
pubmed: 19117470
Nat Commun. 2017 Mar 28;8:14864
pubmed: 28348404
Cancer Cell. 2017 Jun 12;31(6):733-735
pubmed: 28609653
Anal Chem. 2018 May 15;90(10):6292-6299
pubmed: 29671580
Proteomics. 2006 Jan;6(2):571-8
pubmed: 16342243
Anal Chem. 2018 Jul 3;90(13):8065-8071
pubmed: 29741879
Cell. 2016 Jul 28;166(3):755-765
pubmed: 27372738
Anal Chem. 2015;87(10):5181-8
pubmed: 25945896
Anal Chem. 2010 Jul 1;82(13):5598-609
pubmed: 20536156
Anal Bioanal Chem. 2005 Mar;381(5):1082-8
pubmed: 15678335
J Proteome Res. 2009 Feb;8(2):651-61
pubmed: 19159218
Nat Biotechnol. 2002 Mar;20(3):301-5
pubmed: 11875433
Anal Chem. 2008 Aug 1;80(15):6119-26
pubmed: 18593198
Nat Biotechnol. 2005 Jan;23(1):94-101
pubmed: 15592455
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 15;849(1-2):115-28
pubmed: 17049937
Sci Rep. 2011 Sep 13;1:
pubmed: 22034591
Anal Chem. 2008 Jul 1;80(13):5211-8
pubmed: 18484736
Anal Chem. 2017 Jul 18;89(14):7520-7526
pubmed: 28609623
Methods Mol Biol. 2016;1355:53-70
pubmed: 26584918
Methods Mol Biol. 2011;753:309-22
pubmed: 21604132
J Proteome Res. 2014 Dec 5;13(12):5293-309
pubmed: 25337643
Nat Rev Cancer. 2015 Sep;15(9):540-55
pubmed: 26289314
Nat Biotechnol. 2003 Jun;21(6):667-72
pubmed: 12754521
Mol Cell Proteomics. 2010 Apr;9(4):635-47
pubmed: 20047950
Nat Protoc. 2018 Jul;13(7):1632-1661
pubmed: 29988108
Anal Chem. 2017 Nov 7;89(21):11193-11197
pubmed: 29016103
Anal Chem. 2017 Jun 20;89(12):6330-6335
pubmed: 28505427
J Proteome Res. 2017 Dec 1;16(12):4523-4530
pubmed: 29124938
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7
pubmed: 18669648
Anal Chem. 2005 Aug 1;77(15):4962-8
pubmed: 16053310

Auteurs

Kyung-Cho Cho (KC)

Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland 21205 , United States.

Lijun Chen (L)

Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland 21205 , United States.

Yingwei Hu (Y)

Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland 21205 , United States.

Michael Schnaubelt (M)

Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland 21205 , United States.

Hui Zhang (H)

Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland 21205 , United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH